The present invention relates to active esters of compound of Formula I-A and Formula I-B which are used as key intermediates in the synthesis of Micafungin, an antifungal agent and process of preparation of said active esters. The invention also relates to process of preparing Micafungin from said active esters.
...
The present invention relates to intermediate compounds which are used as key intermediates in the synthesis of Romidepsin and process of preparation of these intermediates. The present invention also provides processes for synthesis of Romidepsin in high purity and good yields from said intermediate compounds.
...
A novel process for preparation of Deutetrabenazine ((RR, SS)-l,3,4,6,7-llb-Hexahydro-9,10-di(methoxy-d6)-3-(2-methylpropyl)-2H- benzo [a] quinolizin-2-one) of formula I comprises of methylation of N-(2-(3,4-dihydroxy-phenyl)-ethyl)-formamide compound of formula III with deuteriated methanol (CD3OD or CD3OH) to obta...
A novel process for the preparation of Lifitegrast of the present invention discloses a preparation method of a Lifitegrast and its novel intermediate. The present invention the novel process for preparation of Lifitegrast ((S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3...
ABSTRACT:
The present invention relates to improved manufacturing process for preparing Degarelix Acetate using method of deprotection in solid phase peptide synthesis in which the improvement comprises: treating with Pyrrolidine in Dimethylformamide in small volume. Also disclosed is degarelix of high purity p...
The invention relates to an improved process for preparation of Midostaurin. In one aspect of the invention, to a new process for purifying Midostaurin
The present invention relates to a process for preparation of 6-perdeoxy-6-per-chloro gamma-cyclodextrin which is a key intermediate useful in the synthesis of Sugammadex sodium. The present invention further relates to a process for preparation and purification of Sugammadex sodium.
Title – A METHOD FOR PREPARING GLP-1 ANALOGUE BY SOLID-PHASE PEPTIDE SYNTHESIS
ABSTRACT
The present invention relates to improved process for manufacturing of glucagon-like peptide-1 (GLP-I) and analogs by utilizing Fmoc protected amino acids and synthesizing peptide by solid phase method. The present invention ...
TITLE – A NOVEL PROCESS FOR SYNTHESIS OF CARBETOCIN OCTAPEPTIDE
ABSTRACT
The invention provides a solid-phase synthesis (SPPS) method of Carbetocin, and the method comprises the following steps of: sequentially coupling amino acid containing Fmoc (fluorenylmethoxycarbonyl) protecting group by Rink Amide Resi...
TITLE - A PROCESS FOR THE PREPARATION OF PARATHYROID HORMONE ANALOG.
ABSTRACT
The present invention relates to a process for preparing Abaloparatide by the Solid Phase Process Synthesis (SPPS). The said process employs protected amino acids thereby avoiding problems related to aggregation of peptides on to the ...
TITLE:
A NOVEL PROCESS FOR PREPARATION OF REMDESIVIR.
ABSTRACT
A novel process for the preparation of 2-Ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4- aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy} (phenoxy) phosphoryl] amino} propanoate of formula I (remdesivir) ...
The invention relates to an improved process for the preparation of Saroglitazar. In particular, the invention relates to an improved process for the preparation of Saroglitazar comprising condensation of 2-[2-methyl-5-(4-methylsulfanyl-phenyl)-pyrrol-1-yl] derivate compound of formula II and 2-ethoxy-3-(4-hydroxy-p...
TITLE – AN IMPROVED PROCESS FOR THE PREPARATION OF SAROGLITAZAR CALCIUM
ABSTRACT
The invention relates to an improved process for the preparation of Saroglitazar calcium. In particular, the invention relates to an improved process for the preparation of Saroglitazar calcium comprising condensation of 2-(2-me...
A Stable pharmaceutical composition for an injectable preparation containing Brexanolone for injection and preparation method thereof. The present invention more particularly relates to pharmaceutical composition more particularly, injectable preparation of Brexanolone for intravenous application. The present invent...
Charges
7 Crore
14 June 2019
Axis Bank Limited
7 Crore
29 April 2022
Icici Bank Limited
3 Crore
29 April 2022
Icici Bank Limited
6 Crore
29 April 2022
Others
0
29 April 2022
Others
0
14 June 2019
Axis Bank Limited
0
29 April 2022
Others
0
29 April 2022
Others
0
14 June 2019
Axis Bank Limited
0
29 April 2022
Others
0
29 April 2022
Others
0
14 June 2019
Axis Bank Limited
0
Documents
Form CHG-1-21072020_signed
Instrument(s) of creation or modification of charge;-21072020
Optional Attachment-(1)-21072020
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200721
Form MGT-7-11122019_signed
List of share holders, debenture holders;-09122019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-28112019
Directors report as per section 134(3)-28112019
Form AOC-4-29112019_signed
Evidence of cessation;-06112019
Form DIR-12-06112019_signed
Notice of resignation;-06112019
Form DPT-3-30102019-signed
Form ADT-1-23102019_signed
Copy of written consent given by auditor-15102019
Copy of the intimation sent by company-15102019
Copy of resolution passed by the company-15102019
Form CHG-1-18072019_signed
Instrument(s) of creation or modification of charge;-18072019
CERTIFICATE OF REGISTRATION OF CHARGE-20190718
Form MGT-7-13012019_signed
List of share holders, debenture holders;-27122018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-27102018
Form AOC-4-27102018_signed
Form PAS-3-25092018_signed
Evidence of cessation;-14092018
Notice of resignation;-14092018
Form DIR-12-14092018_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-05092018